| Pharmaceutical Information |
| Drug Name |
Remifentanil |
| Drug ID |
BADD_D02430 |
| Description |
Remifentanil (marketed by Abbott as Ultiva) is a potent ultra short-acting synthetic opioid given to patients during surgery for pain relief and adjunctive to an anaesthetic. Remifentanil is a specific mu-type-opioid receptor agonist which means it reduces sympathetic nervous system tone, and causes respiratory depression and analgesia. |
| Indications and Usage |
For use during the induction and maintenance of general anesthesia. |
| Marketing Status |
Not Available |
| ATC Code |
N01AH06 |
| DrugBank ID |
DB00899
|
| KEGG ID |
D08473
|
| MeSH ID |
D000077208
|
| PubChem ID |
60815
|
| TTD Drug ID |
D0T5OX
|
| NDC Product Code |
Not Available |
| Synonyms |
Remifentanil | 3-(4-Methoxycarbonyl-4-((1-oxopropyl)phenylamino)-1-piperidine)propanoic Acid Methyl Ester | Remifentanil Hydrochloride | Ultiva | Remifentanil Monohydrochloride | GI 87084B | GI87084B | GI-87084B |
|
| Chemical Information |
| Molecular Formula |
C20H28N2O5 |
| CAS Registry Number |
132875-61-7 |
| SMILES |
CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
